A Six Month Randomized Controlled Clinical Trial of Lung Flute in Patients With Chronic Obstructive Pulmonary Disease

NCT ID: NCT01186822

Last Updated: 2015-01-30

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 69 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-09-30
• Study Completion Date: 2013-12-31

Brief Summary

This is a 26 week randomized controlled study. The study consists of, in order, an enrollment visit, followed by clinic visits at 2 weeks, 14 weeks and at 26 weeks. There will also be telephonic assessments at 8 weeks and 20 weeks. Clinic visits will involve comprehensive assessments of the patients lung condition, including post-bronchodilator spirometry, Shuttle walk distance, BODE index, health status (SGRQ) and symptoms (CCQ). Sputum and serum samples will also be collected at these visits for microbiological and inflammation analysis. Sputum will be obtained with the Lung Flute as an induction device and Pulse Oximetry will be assessed prior to and after use of the Lung Flute. Clinic and telephonic visits will collect information regarding compliance with the use of the Lung Flute, adverse events and exacerbation history.

Conditions

COPD

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Lung Flute for BHT

The Lung Flute arm participants were instructed to blow twice in to the Lung Flute device vigorously enough to make the reed oscillate, followed by 5 normal breaths. This was repeated 10 times, followed by 3 huff coughs to complete 1 cycle. Two such cycles were recommended twice a day. One of these cycles was performed under supervision of the study personnel at the time of enrollment and at each subsequent study visit. Baseline COPD medication regimen was continued in all participants, although the primary physicians of the participants could make medically necessary changes. Chest physical therapy, additional breathing exercises and formal pulmonary rehabilitation programs were not prescribed to any of the participants during the study.

Group Type: EXPERIMENTAL

Lung Flute

Intervention Type: DEVICE

Used twice daily

No intervenstion

No intervention. Same population.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Lung Flute

Used twice daily

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Male or female subjects between and including the ages of 30 and 80 years. Females of childbearing potential may be included provided they are not pregnant or are not nursing.

2. Subjects with a diagnosis of moderate to very severe chronic obstructive pulmonary disease as defined by the Global Initiative for COPD (GOLD, 2008 update) and who meet the following criteria for stage ll - IV disease:

a) Subjects must have a post-bronchodilator FEV1/FEV ratio <70% and FEV1 of <80% of the predicted value for age, height, and sex using the NHANES III standards (Hankinson, 1999).

3. Subjects must have a smoking history of at least 10 pack-years.

4. Subjects must have stable disease for at least 1 month prior to enrollment with no changes in the maintenance treatment for COPD in this period.

-

Exclusion Criteria

1. History of an exacerbation or other significant disease instability during the month preceding enrollment.

2. A primary diagnosis of asthma or bronchiectasis.

3. Inability to vibrate the reed of the Lung Flute® consistently because of severely expiratory flow rate.

4. Subject with any evidence of significant concomitant clinical disease that, in the opinion of the investigator, could interfere with the conduct of the study or safety of the subject.

5. Pregnant or nursing females or females intending to become pregnant during the course of the study.

6. Use of any investigational drug within one month or 6 half-lives (which-ever is greater) of the enrollment visit.

7. Inability to comprehend or willingness to follow the study requirements including attendance at out-patient clinic visit and participation in testing as called for by the protocol.

8. Patients currently using the Lung Flute. -

• Minimum Eligible Age: 30 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Nicolaas J Smit PhD

INDUSTRY

Sponsor Role: lead

Responsible Party

Nicolaas J Smit PhD

Dr. S. Sethi

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Sanjay Sethi, MD

Role: PRINCIPAL_INVESTIGATOR

VA WNY Healthcare System

Locations

VA WNY Healthcare System

Buffalo, New York, United States

Countries

United States

References

Sethi S, Yin J, Anderson PK. Lung flute improves symptoms and health status in COPD with chronic bronchitis: A 26 week randomized controlled trial. Clin Transl Med. 2014 Sep 23;3:29. doi: 10.1186/s40169-014-0029-y. eCollection 2014.

Reference Type: DERIVED

PMID: 25625006 (View on PubMed)

Other Identifiers

LF6mo

Identifier Type: -

Identifier Source: org_study_id